Corbridge Group Philippines, Inc. Report issue

For profit Phase 3
Founded: Quezon City Philippines (2005)
Status: No NME R&D (2005)

Organization Overview

First Clinical Trial
2009
NCT01000545
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2009

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 3 Trials (1)

sulodexide (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Kidney Diseases (Phase 3)

Renal Insufficiency, Chronic (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 1
  • # of Trial APIs: 1